세계의 집단검진 시장 보고서(2025년)

Population screening is a systematic process aimed at evaluating the prevalence of a specific trait or disease within an entire population or a subgroup. The objective is to effectively identify individuals or groups at risk of developing a particular condition, distinguishing it from diagnostic testing.

The primary products associated with population screening include hardware equipment, testing or laboratory services, and analytics or interpretation tools. Hardware assumes a pivotal role in population screening by providing essential tools and equipment necessary for conducting screening tests, collecting data, and delivering healthcare services. Businesses engaged in population screening cater to various age groups, including males and females under 15, those between 15 and 65, and individuals aged 65 and above. These screening services are typically offered by a range of entities, including hospitals, research institutes, and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The population screening research report is one of a series of new reports from The Business Research Company that provides population screening market statistics, including the population screening industry's global market size, regional shares, competitors with population screening market share, detailed population screening market segments, market trends and opportunities, and any further data you may need to thrive in the population screening industry. This population screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The population screening market size has grown strongly in recent years. It will grow from $29.31 billion in 2024 to $31.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to disease prevention initiative, government health policies, rising healthcare costs, increased disease awareness.

The population screening market size is expected to see strong growth in the next few years. It will grow to $41.4 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to shift towards personalized medicine, aging population and chronic diseases, integration of ai and data analytics, expansion of screening access. Major trends in the forecast period include advancements in medical technology, genomics and precision screening, telehealth and remote screening, multi-disease screening panels, health equity and accessibility.

The forecast of 7.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of Artificial intelligence-powered screening software and liquid biopsy tools sourced from the UK and Sweden, thereby reducing early detection rates and elevating public health program costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is projected to drive the growth of the population screening market in the future. Cancer occurs when certain cells in the human body grow abnormally and spread to other areas of the body. Population screening can facilitate early detection of cancer, making it more treatable and improving prognosis. For example, in January 2023, reports from the American Cancer Society Inc., a US-based voluntary health organization, indicated that there were 608,570 cancer deaths in 2022, alongside an estimated 1.9 million new cancer cases, compared to 606,520 cancer deaths in 2021. Therefore, the rising prevalence of cancer is fueling the growth of the population screening market.

The expanding proportion of aging individuals is anticipated to propel the growth of the population screening market. Aging individuals encompass those who are in the process of growing older or have reached advanced age milestones. Regular population screenings tailored to the specific health needs of aging individuals can significantly contribute to successful aging and better health outcomes. For instance, in June 2023, The United States Census Bureau, a governmental agency in the United States, reported a 0.2-year increase in the country's median age, reaching 38.9 years in 2022, indicating a continual aging trend within the population. Consequently, the growing proportion of aging individuals serves as a driving force behind the expansion of the population screening market.

Leading companies in the population screening market are developing advanced services like newborn mass screening to improve early detection and enhance infant health outcomes. Newborn mass screening is a public health initiative in which newborns are tested shortly after birth for various genetic, metabolic, hormonal, and functional disorders that may not be evident at birth but can result in serious health issues if untreated. For example, in May 2024, Shimadzu Techno-Research Inc., a contract analysis firm and subsidiary of Japan-based Shimadzu Corporation, launched a new contract service that conducts polymerase chain reaction (PCR) testing for expanded newborn mass screening. This service will screen for conditions like severe combined immunodeficiency (SCID), B-cell deficiency (BCD), and spinal muscular atrophy (SMA), which affect a small percentage of newborns but require immediate intervention upon diagnosis.

Major players in the population screening market are introducing new products for targeted disease screening to enhance their profitability. Specific disease screening within population screening refers to the focused identification of individuals at risk for certain diseases within a larger population. For instance, in October 2023, DELFI Diagnostics, a US-based company specializing in advanced machine learning and fragment omics, unveiled First Look Lung. This innovative blood test employs whole-genome machine learning to analyze cell-free DNA fragments as cancer markers. This convenient laboratory-developed test can be easily integrated into routine blood screenings. Its notable features include a 99.7% negative predictive value, effectively ruling out lung cancer, and high sensitivity for detecting early-stage disease. The test provides personalized, actionable reports to healthcare providers, offering a potential solution to improve the low lung cancer screening rates in the United States.

In January 2024, Natera, a US-based biotechnology firm, acquired Invitae for an undisclosed sum. This acquisition aims to broaden Natera's capabilities in non-invasive prenatal and carrier screening, enhancing its service offerings and supporting a larger number of patients and providers. Invitae is a US-based company that offers advanced genetic testing services, including those related to population screening.

Major companies operating in the population screening market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

North America was the largest region in the population screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the population screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The population screening market consists of revenues earned by entities by providing services such as next-generation sequencing (NGS) and microarray-based genotyping, imaging tests, mammography screening, colonoscopy screening, cholesterol screening, and blood pressure screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The population screening market also includes sales of smartphone-based biosensors, kits, and chips, which are used in providing population screening services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Population Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on population screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for population screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The population screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Hardware Equipment; Testing Or Lab; Analytics Or Interpretation
• 2) By Gender: Male; Female
• 3) By Age: Ages Less Than 15; 15-65; Ages 65 And Above
• 4) By Business: Hospitals; Research Institutes; Diagnostic Labs
• Subsegments:
• 1) By Hardware Equipment: Diagnostic Devices; Sample Collection Devices; Imaging Equipment
• 2) By Testing Or Lab: Laboratory Testing Kits; Point-Of-Care Testing; Blood And Urine Testing Services
• 3) By Analytics Or Interpretation: Software Solutions For Data Analysis; Interpretation Services; Reporting Tools
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Quest Diagnostics Incorporated; Eurofins Scientific SE; Agilent Technologies Inc.; Sonic Healthcare Limited; Illumina Inc.; SYNLAB International GmbH; Quidel Corporation; Bio-Rad Laboratories Inc.; Unilabs; Qiagen N.V.; Exact Sciences Corporation; ARUP Laboratories Inc.; LGC Limited; OPKO Health Inc.; Natera Inc.; Cerba HealthCare S.A.S; Invitae Corp; Amedes Holding GmbH; Grail; Luminex Corporation; Novogene Co. Ltd.; Trinity Biotech; Gene by Gene Ltd.; Innova Medical Group Inc.; Evoq Technologies LLC; LabPLUS
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Population Screening Market Characteristics

3. Population Screening Market Trends And Strategies

4. Population Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Population Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Population Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Population Screening Market Growth Rate Analysis
• 5.4. Global Population Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Population Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Population Screening Total Addressable Market (TAM)

6. Population Screening Market Segmentation

• 6.1. Global Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hardware Equipment
• Testing Or Lab
• Analytics Or Interpretation
• 6.2. Global Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male
• Female
• 6.3. Global Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ages Less Than 15
• 15-65
• Ages 65 And Above
• 6.4. Global Population Screening Market, Segmentation By Business, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Institutes
• Diagnostic Labs
• 6.5. Global Population Screening Market, Sub-Segmentation Of Hardware Equipment, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Devices
• Sample Collection Devices
• Imaging Equipment
• 6.6. Global Population Screening Market, Sub-Segmentation Of Testing Or Lab, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing Kits
• Point-Of-Care Testing
• Blood And Urine Testing Services
• 6.7. Global Population Screening Market, Sub-Segmentation Of Analytics Or Interpretation, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software Solutions For Data Analysis
• Interpretation Services
• Reporting Tools

7. Population Screening Market Regional And Country Analysis

• 7.1. Global Population Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Population Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Population Screening Market

• 8.1. Asia-Pacific Population Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Population Screening Market

• 9.1. China Population Screening Market Overview
• 9.2. China Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Population Screening Market

• 10.1. India Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Population Screening Market

• 11.1. Japan Population Screening Market Overview
• 11.2. Japan Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Population Screening Market

• 12.1. Australia Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Population Screening Market

• 13.1. Indonesia Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Population Screening Market

• 14.1. South Korea Population Screening Market Overview
• 14.2. South Korea Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Population Screening Market

• 15.1. Western Europe Population Screening Market Overview
• 15.2. Western Europe Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Population Screening Market

• 16.1. UK Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Population Screening Market

• 17.1. Germany Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Population Screening Market

• 18.1. France Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Population Screening Market

• 19.1. Italy Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Population Screening Market

• 20.1. Spain Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Population Screening Market

• 21.1. Eastern Europe Population Screening Market Overview
• 21.2. Eastern Europe Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Population Screening Market

• 22.1. Russia Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Population Screening Market

• 23.1. North America Population Screening Market Overview
• 23.2. North America Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Population Screening Market

• 24.1. USA Population Screening Market Overview
• 24.2. USA Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Population Screening Market

• 25.1. Canada Population Screening Market Overview
• 25.2. Canada Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Population Screening Market

• 26.1. South America Population Screening Market Overview
• 26.2. South America Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Population Screening Market

• 27.1. Brazil Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Population Screening Market

• 28.1. Middle East Population Screening Market Overview
• 28.2. Middle East Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Population Screening Market

• 29.1. Africa Population Screening Market Overview
• 29.2. Africa Population Screening Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Population Screening Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Population Screening Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Population Screening Market Competitive Landscape And Company Profiles

• 30.1. Population Screening Market Competitive Landscape
• 30.2. Population Screening Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Population Screening Market Other Major And Innovative Companies

• 31.1. Eurofins Scientific SE
• 31.2. Agilent Technologies Inc.
• 31.3. Sonic Healthcare Limited
• 31.4. Illumina Inc.
• 31.5. SYNLAB International GmbH
• 31.6. Quidel Corporation
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. Unilabs
• 31.9. Qiagen N.V.
• 31.10. Exact Sciences Corporation
• 31.11. ARUP Laboratories Inc.
• 31.12. LGC Limited
• 31.13. OPKO Health Inc.
• 31.14. Natera Inc.
• 31.15. Cerba HealthCare S.A.S

32. Global Population Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Population Screening Market

34. Recent Developments In The Population Screening Market

35. Population Screening Market High Potential Countries, Segments and Strategies

• 35.1 Population Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Population Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Population Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer